(News Bulletin 247) – Bayer shows the biggest drop in the DAX index on Wednesday on the Frankfurt Stock Exchange, penalized by the rise in concerns about the Chinese economy and a lowering of Berenberg’s recommendation.
In a study released in the morning, the broker indicates that he has reduced his advice on the title from ‘buy’ to ‘keep’ with a price target lowered from 66 to 60 euros.
In his note, Berenberg believes that Bill Anderson, the new chief executive, showed ‘disarming sincerity’ in describing the problems faced by the chemical and pharmaceutical group recently, namely its numerous ongoing litigations, a too big bureaucracy and too much debt.
The broker is however delighted that the business leader has, unlike his predecessors, raised the possible scenario of a split, which he believes could begin to materialize next year.
If he considers a dismantling ‘probable’, Berenberg underlines that the title is still traded on the basis of an enterprise value / EBITDA ratio of 9x, a level which he considers excessive for a group which should have according to him struggling to grow its bottom line over the next two years due to patent losses and falling commodity prices.
He also says he is ‘uninspired’ by the unconvincing results displayed so far by the company in its trials relating to the PCB.
Around 10:35 a.m., the Bayer title lost nearly 1.3%.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
